Skip to main content
. Author manuscript; available in PMC: 2013 Feb 1.
Published in final edited form as: Bone. 2011 Aug 11;50(2):490–498. doi: 10.1016/j.bone.2011.08.005

Table II.

Male static and dynamic tibia histomorphometry after five and eight weeks of risperidone treatment.

Five Week Treatment Eight Week Treatment


Control
(n=6–8)
Risperidone
(n=8)
p value Control
(n=7–8)
Risperidone
(n=8)
p value
BV/TV (%) 8.8 ± 0.4 7.3 ± 0.5* 0.03 9.9 ± 1.1 6.9 ± 0.7* 0.03
Tb.Th (µm) 29.9 ± 1.2 27.2 ± 1.0 0.10 31.3 ± 1.2 28.5 ± 0.9 0.09
Tb.N (/mm) 2.95 ± 0.12 2.66 ± 0.12 0.11 3.12 ± 0.22 2.38 ± 0.19* 0.03
Tb.Sp (µm) 313 ± 15 353 ± 16 0.09 301 ± 24 415 ± 42* 0.03
MS/BS (%) 27.7 ± 4.2 23.2 ± 2.1 0.32 26.3 ± 2.5 27.6 ± 2.3 0.71
MAR (µm/day) 2.03 ± 0.09 2.11 ± 0.18 0.72 1.18 ± 0.08 1.02 ± 0.07 0.15
BFR/BS (µm3/µm2/year) 199 ± 24 180 ± 22 0.57 113 ± 14 103 ± 13 0.61
BFR/BV (%/year) 1301 ± 150 1273 ± 146 0.90 706 ± 61 741 ± 113 0.78
BFR/TV (%/year) 117 ± 17 92 ± 10 0.21 76 ± 14 49 ± 7 0.13
Ob.S/BS (%) 5.2 ± 1.1 6.5 ± 1.3 0.43 2.3 ± 0.6 3.0 ± 1.0 0.53
N.Ob/T.Ar (/mm2) 26.2 ± 4.9 28.9 ± 4.9 0.70 12.2 ± 3.2 11.2 ± 3.0 0.81
N.Ob/B.Pm (/mm) 4.6 ± 1.0 5.4 ± 0.8 0.57 2.1 ± 0.5 2.4 ± 0.7 0.78
OV/TV (%) 0.044 ± 0.011 0.047 ± 0.011 0.89 0.012 ± 0.004 0.015 ± 0.006 0.63
OS/BS (%) 3.2 ± 0.8 3.3 ± 0.7 0.89 0.8 ± 0.3 1.6 ± 0.6 0.24
O.Th (µm) 2.1 ± 0.3 2.5 ± 0.2 0.35 2.7 ± 0.4 1.6 ± 0.4 0.08
Oc.S/BS (%) 2.5 ± 0.6 5.7 ± 0.9* 0.01 1.5 ± 0.3 2.9 ± 0.5* 0.02
N.Oc/T.Ar (/mm2) 6.4 ± 1.6 11.8 ± 1.2* 0.02 3.3 ± 0.6 5.2 ± 0.9 0.11
N.Oc/B.Pm (/mm) 1.1 ± 0.3 2.3 ± 0.3* 0.01 0.6 ± 0.1 1.1 ± 0.1* 0.01
ES/BS (%) 0.98 ± 0.20 2.56 ± 0.38* <0.01 0.53 ± 0.14 0.93 ± 0.27 0.21
*

p<0.05 by two-tailed Student’s t-test.

Abbreviations: BV, bone volume; TV, tissue volume; Tb., trabecular; N, number; Th, thickness; Sp, separation; MS, mineralizing surface; BS, bone surface; MAR, mineral apposition rate; BFR, bone formation rate; Ob.S, osteoblast surface; N.Ob, number of osteoblasts; T.Ar, tissue area; B.Pm, bone perimeter; OV, osteoid volume; OS, osteoid surface; O.Th, osteoid thickness; Oc.S, osteoclast surface; N.Oc, number of osteoclasts; ES, eroded surface.